Morten Harket, lead singer of a-ha, has Parkinson's disease
Morten Harket has revealed he has Parkinson's disease.
The singer of a-ha, the band behind the 1985 hit and innovatively animated music video 'Take On Me,' shared the news during an interview with the group's biographer.
'I've got no problem accepting the diagnosis,' Harket said. 'With time, I've taken to heart my 94-year-old father's attitude to the way the organism gradually surrenders: 'I use whatever works'.'
Harket, 65, explained why he wanted to share his diagnosis publicly.
'Acknowledging the diagnosis wasn't a problem for me; it's my need for peace and quiet to work that has been stopping me. I'm trying the best I can to prevent my entire system from going into decline,' he said. 'It's a difficult balancing act between taking the medication and managing its side effects. There's so much to weigh up when you're emulating the masterful way the body handles every complex movement, or social matters and invitations, or day-to-day life in general.'
According to Mayo Clinic, 'Parkinson's disease is a movement disorder of the nervous system that worsens over time.'
Harket had 'advanced brain surgery' at the Mayo Clinic, which along with medication, 'have softened the impact of his symptoms,' the a-ha biographer, Jan Omdahl, wrote.
'In June 2024, Morten underwent a neurosurgical procedure in which electrodes were implanted deep inside the left side of his brain. These are connected to a small pacemaker-like device placed under the skin of the upper chest that sends electrical impulses through the electrodes into the brain,' Omdahl wrote. 'The method is called deep brain stimulation (DBS) and is among the most advanced treatments in neurology. The procedure had the desired effect: with the right electrical impulses now reaching Morten's brain, many of his physical symptoms practically vanished. In December 2024 he underwent a similar procedure on the right side of his brain, which was also successful.'
Harket's voice, however, has been affected, he said.
'The problems with my voice are one of many grounds for uncertainty about my creative future,' Harket said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults
Plant-Based Supplement Includes Five Individual Ingredients Studied for Their Role in Supporting Memory and Focus Denver, June 06, 2025 (GLOBE NEWSWIRE) -- BrainDefender Research today announced the launch of , a new cognitive wellness formula developed to support focus, mental clarity, and memory in adults. Manufactured in a GMP-certified facility in the United States, the product is designed for individuals seeking to maintain healthy cognitive function through natural, plant-based supplementation. The new formula features a combination of Ginkgo Biloba, Bacopa Monnieri, Huperzine-A, Phosphatidylserine, and N-Acetyl-L-Carnitine—ingredients that have each been individually studied for their potential roles in brain function. BrainDefender Research emphasizes that the supplement is intended for use as part of a wellness routine to support cognitive performance and healthy aging. 'Consumer interest in natural brain support has grown significantly in recent years,' said a spokesperson for BrainDefender Research. 'We developed this product to offer adults a well-rounded option for supporting mental clarity, focus, and memory performance using recognizable, research-supported ingredients.' The company recommends consistent daily use over a 90-day period for best results and offers a 60-day refund policy for customer satisfaction. The product is available for purchase in 30-day, 90-day, and 180-day supply options to accommodate individual wellness goals. AvailabilityBrainDefender Memory Support Supplement can be ordered directly through the company's official website and is also offered via the ClickBank platform. Domestic orders are typically delivered within 5–7 business days, while international shipping may take 10–12 business days. About BrainDefender ResearchBrainDefender Research is a U.S.-based wellness company focused on the development of cognitive support supplements using plant-based ingredients. All products are manufactured in GMP-certified facilities to ensure quality and safety in every batch. DisclaimerThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a licensed healthcare provider before beginning any new supplement routine, especially if taking medications or managing a medical condition. Media Contact Email: support@ Phone: (855) 473-4405 CONTACT: Email: support@ Phone: (855) 473-4405Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
an hour ago
- Forbes
‘The Phoenician Scheme' Reviews: Do Critics Buy Into Wes Anderson's Comedy?
Michael Cera, Benicio Del Toro and Mia Threapleton in "The Phoenician Scheme." Director Wes Anderson's The Phoenician Scheme — starring Benicio Del Toro, Tom Hanks, Scarlett Johansson and Bryan Cranston — is now in theaters. How are critics receiving the film? Rated PG-13, The Phoenician Scheme opened in limited release on May 31 before expanding to a wide release on Friday. Also starring Michael Cera, Riz Ahmed, Mathieu Amalric, Richard Ayoade, Jeffrey Wright, Benedict Cumberbatch, Rupert Friend and Hope Davis, The Phoenician Scheme held its world premiere at the 2025 Cannes Film Festival in May. The logline for The Phoenician Scheme reads, "The story of a family and a family business." Featuring a screenplay by Anderson and Roman Coppola, the offbeat comedy follows the story of European businessman Zsa-zsa Korda (Del Toro) and his only daughter and sole heir, a nun named Sister Liesel (Threapleton), who are each being targeted by assassins and schemers. As of Friday, Rotten Tomatoes critics have collectively given The Phoenician Scheme a 78% 'fresh' rating based on 185 reviews. The RT Critics Consensus for the film reads, 'A caper made with all the intricacy of a Rube Goldberg machine, The Phoenician Scheme doesn't deviate from Wes Anderson's increasingly ornate style but delivers the formula with mannered delicacy.' Audiences on RT gave the film a 73% 'fresh' score on the critic aggregation site's Popcornmeter based on 100-plus verified user ratings. Kyle Smith of The Wall Street Journal is among the top critics on RT who gives The Phoenician Scheme a 'fresh' rating on RT, writing, 'Given that The Phoenician Scheme essentially concludes by saying, as some of the director's other movies did, 'Forgive your ridiculous dad for his failings,' its major attraction is the whimsy with which it is decorated, or suffused, or infested.' Also giving The Phoenician Scheme a 'fresh' take on RT is Ann Hornaday of the Washington Post, who writes, "At its fleeting best — in its meditation on the transactional and the transcendent — this one feels like it's reaching for something more than surface charm." In addition, Justin Chang of The New Yorker gives the film a 'fresh' rating on RT, albeit with some minor reservations, writing, 'The result is more digestible, though also less moving, than Anderson's recent Asteroid City, but it does have a stealth emotional weapon in [Mia] Threapleton's Liesl, who exudes the intelligence and self-possession of a young Anna Karina.' Coleman Spilde of Salon is among the top critics on RT who gives The Phoenician Scheme a 'rotten' rating, writing in his summary, 'The resulting product is just that: a product, with all of the matte pastel appeal of Anderson's oeuvre, yet little of its memorable charm.' Dana Stevens of Slate also gives The Phoenician Scheme a 'rotten' rating on RT, writing, 'For all its exquisite boxes-within-boxes compositions and cleverly designed sets, this whole movie unfolded for me as if behind a thick pane of emotion-proof glass.' Nicholas Barber of the BBC wasn't impressed by the film, either, writing in his 'rotten' take on RT, 'Some directors boast that they make the films that they want to see, and they don't care about pleasing anyone else. In the case of The Phoenician Scheme, it feels as if Anderson and his team were enjoying it more than audiences ever will.' The Phoenician Scheme is now playing in theaters in wide release.
Forbes
2 hours ago
- Forbes
‘Atomic Heart 2' Is Confirmed, And Its Trailer Is Unmissable
Fresh off the back of celebrating 10 million players for its breakout hit Atomic Heart, Mundfish has finally marked the occasion in the way we hoped: by announcing Atomic Heart 2. At 2025's Summer Game Fest, it dropped its first trailer, and let's be honest — it's one of the best we've seen in a long time. Weird vehicles! 3D-printed whales! Surfing 'humans' with seethrough skin! Parachutes! Horizon Zero Dawn-style mechs! Grapple-hook wall running! Strip clubs with slides! Massive, meaty monsters! And, of course, the return of those sexy Soviet robots — all to the tune of Don't Stop Me Now by Queen! Are you not entertained? Atomic Heart 2, which still lacks a defined release date, will return the action-FPS to PC, PS5, and Xbox Series X/S. Sharing the same retrofuturistic alt-history dystopia as its predecessor, it aims to be bolder with its approach to exploration, narrative, RPG elements, and — ironically — freedom. Most importantly, Atomic Heart 2 aims to showcase the impact of its tech-first, morality-second Soviet Union on a global scale. The utopian world promised in the early stages of the OG Atomic Heart, which was arguably home to the most gorgeous FPS art direction in recent memory, is shattered, but still somehow stunning. Humans no longer live in harmony with the robots and AI they created, giving way to abject chaos — naturally, only you can stop worldwide collapse. Finer details are next to non-existent, save for the exhilarating morsels provided by the trailer. Mundfish promises enhanced combat, allowing players to use both hands simultaneously by combining glove abilities with melee and ranged weapons — a massive boost to the original, and one that'll hopefully be complemented by more balanced and fair combat. Look, I wasn't the biggest fan of Atomic Heart when it landed in 2023. That won't stop me being thoroughly reinvigorated by the Atomic Heart 2 trailer, which is one of the most hilariously bats*** things I've seen in a long time. Promise is one thing, and execution is another — here's hoping that Mudfish capitalizes on feedback.
